| 000 | 01773 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250515204338.0 | ||
| 264 | 0 | _c20100308 | |
| 008 | 201003s 0 0 eng d | ||
| 022 | _a1474-547X | ||
| 024 | 7 |
_a10.1016/S0140-6736(09)61969-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCurrie, Craig J | |
| 245 | 0 | 0 |
_aSurvival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cFeb 2010 |
||
| 300 |
_a481-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 |
_aBlood Glucose _xanalysis |
| 650 | 0 | 4 | _aCause of Death |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlycated Hemoglobin _xanalysis |
| 650 | 0 | 4 |
_aHeart Diseases _xepidemiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aInjections, Subcutaneous |
| 650 | 0 | 4 |
_aInsulin _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aSex Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aUnited Kingdom _xepidemiology |
| 700 | 1 | _aPeters, John R | |
| 700 | 1 | _aTynan, Aodán | |
| 700 | 1 | _aEvans, Marc | |
| 700 | 1 | _aHeine, Robert J | |
| 700 | 1 | _aBracco, Oswaldo L | |
| 700 | 1 | _aZagar, Tony | |
| 700 | 1 | _aPoole, Chris D | |
| 773 | 0 |
_tLancet (London, England) _gvol. 375 _gno. 9713 _gp. 481-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S0140-6736(09)61969-3 _zAvailable from publisher's website |
| 999 |
_c19484925 _d19484925 |
||